|
Your eTMF as a Strategic Asset - Attend the Roundtable Join your peers at a Clinical Roundtable on improving sponsor/CRO/site collaboration to speed study start up and maintaining inspection readiness. Meet with industry leaders, including Ken Getz, director of sponsored research at the Tufts Center for the Study of Drug Development. With 20+ years of original research experience, Ken Getz is an internationally recognized expert on R&D and clinical trial management practices and trends. Relevant topics: Most companies can get substantial business value out of an eTMF. Leave with a better understanding of how to effectively leverage an eTMF as a strategic asset. Expert speakers: In addition to Ken Getz, hear from Linda Sullivan, chief operating officer of Metrics Champion Consortium, and Tamika Jackson, president at Corementum, whose clients include Gilead, Allergan, Elan, Dow, Novartis, and Johnson & Johnson. Interact with these experts in an intimate, collaborative setting. Valuable networking: Attendees from both large and small pharma are signed up already. Learn from other attendees and build relationships.
|
Clinical Rountable: Your eTMF as a Strategic Asset
Featured Speakers
|
Ken Getz
Linda Sullivan
Tamika Jackson